Assistant Scientist, Viral Vector Process Development

Bristol Myers Squibb; Seattle (WA); On-site; USD 52,000 - 59,000; Full time

Job summary

Bristol Myers Squibb is seeking an Assistant Scientist to join the Gene Delivery & Editing Process Development team in Seattle, WA. The role supports upstream and downstream operations in our 250 L pilot lab for production of AAV and Lentiviral vectors used for gene delivery and gene editing of our cell therapy products.

The candidate will help advance scalable, manufacturing-friendly viral vector processes and provide non GMP grade viral vectors for pipeline supporting studies, collaborating

Qualifications

• M.S. or B.S. in Chemical Engineering, Bioengineering, Biochemistry, Molecular Biology, Virology, or related disciplines.
• 0-2 years of industry experience in process development or related work.
• Independently motivated with the ability to multitask and work in teams.
• Ability to communicate clearly and concisely through oral presentation and technical writing.

Responsibilities

• Hands-on experience in upstream (cell culture, bioreactor operation, and transfection conditions) and downstream ( depth filtration, normal flow filtration, tangential flow filtration, chromatography) unit operations for viral vector production.
• Prepare buffers and process solutions for pilot scale productions.
• Contribute to planning and design of experiments, execution and independent analysis of data.
• Maintain proper documentation of process data.

Education

MS or BS in Chemical Engineering, Bioengineering, Biochemistry, Molecular Biology, Virology, or related disciplines

Tools

AKTA

UF/DF

Sterile Filtration

HPLC

ELISA

Job description

Bristol Myers Squibb is seeking an Assistant Scientist to join the Gene Delivery & Editing Process Development team in Seattle, WA. The role supports upstream and downstream operations in our 250 L pilot lab for production of AAV and Lentiviral vectors used for gene delivery and gene editing of our cell therapy products.

The candidate will help advance scalable, manufacturing-friendly viral vector processes and provide non GMP grade viral vectors for pipeline supporting studies, collaborating